Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1 Glioblastoma 1 Epilepsy 1 Colorectal Neoplasms 1

Interventions

venetoclax 124 Azacitidine 96 Cytarabine 71 fludarabine 44 Specimen Handling 38 Cyclophosphamide 38 Daunorubicin 27 Decitabine 26 Biopsy 25 Idarubicin 24 Granulocyte Colony-Stimulating Factor 21 gilteritinib 18 Injections 18 fludarabine phosphate 17 Whole-Body Irradiation 17 Melphalan 16 Busulfan 16 Stem Cell Transplantation 15 Mycophenolic Acid 15 ivosidenib 13 Cladribine 13 decitabine and cedazuridine drug combination 12 Gemtuzumab 12 Tacrolimus 11 CPX-351 11 X-Rays 10 Filgrastim 10 revumenib 9 enasidenib 9 Cyclosporine 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Leukemia, Myeloid, Acute × Sulfasalazine × Clear all

NCT05580861 2024-05-29

SALMA

Assistance Publique - Hôpitaux de Paris

Phase 1/2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡